Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- Supporting Nurses Under Pressure.
- Unlocking a Cure for a Disease That Afflicts Millions.
- Microplastics: Small Particles, Big Problem?
- Rutgers Researchers Use Artificial Intelligence to Predict Cardiovascular Disease.
- Rutgers Office for Research Using Data to Inform and Improve the Rutgers Research Enterprise.